source
- Former Akero executives launch Avere Therapeutics, unveiling China-sourced pipeline drug and reverse merger planThe former leadership team of Akero Therapeutics announced the creation of a new in‑licensing company called Avere Therapeutics. The launch was made public on Tuesday and includes a pipeline drug…
- BIO 2026 in San Diego features executive interviews on biotech trends and opportunitiesThe BIO International Convention gathered more than 20,000 life‑science leaders in San Diego, serving as a major forum for biotech discussion. During the event, Fierce conducted a series of video…